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Abstract
Testing one SNP at a time does not fully realise the potential of genome-wide association studies to identify multiple causal
variants, which is a plausible scenario for many complex diseases. We show that simultaneous analysis of the entire set of
SNPs from a genome-wide study to identify the subset that best predicts disease outcome is now feasible, thanks to
developments in stochastic search methods. We used a Bayesian-inspired penalised maximum likelihood approach in which
every SNP can be considered for additive, dominant, and recessive contributions to disease risk. Posterior mode estimates
were obtained for regression coefficients that were each assigned a prior with a sharp mode at zero. A non-zero coefficient
estimate was interpreted as corresponding to a significant SNP. We investigated two prior distributions and show that the
normal-exponential-gamma prior leads to improved SNP selection in comparison with single-SNP tests. We also derived an
explicit approximation for type-I error that avoids the need to use permutation procedures. As well as genome-wide
analyses, our method is well-suited to fine mapping with very dense SNP sets obtained from re-sequencing and/or
imputation. It can accommodate quantitative as well as case-control phenotypes, covariate adjustment, and can be
extended to search for interactions. Here, we demonstrate the power and empirical type-I error of our approach using
simulated case-control data sets of up to 500 K SNPs, a real genome-wide data set of 300 K SNPs, and a sequence-based
dataset, each of which can be analysed in a few hours on a desktop workstation.
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Introduction
The ideal analysis of a genome-wide association (GWA) study for
a complex disease would involve analysing all the SNP genotypes
simultaneously to find a set of SNPs most associated with disease
risk. Such an analysis can improve performance over single-SNP
tests, since a weak effect may be more apparent when other causal
effects are already accounted for, but also because a false signal may
be weakened by inclusion in the model of a stronger signal from a
true causal association. To date, analysing all SNPs simultaneously
has seemed infeasible, since current GWA platforms can type over
one million SNPs, and even larger variable sets may not be far away
as genome-wide re-sequencing advances.
We exploit recent advances in stochastic search algorithms [1,2]
to develop a computationally efficient tool to simultaneously
analyse k SNPs typed in n individuals for association with case-
control status, where k » n. We formulate the problem as variable
selection in a logistic regression analysis that includes a covariate
for each SNP. Our aim is to find a subset of SNPs (a ‘‘model’’) that
best explains the case-control status subject to a specified error
rate. The number of possible models is 2
k and since k is typically of
the order of 10
6, classical methods such as forward-backward
variable selection are computationally expensive and are liable to
find sub-optimal modes [3]. Bayesian stochastic search methods
have been used to tackle variable selection problems, typically
using the ‘‘slab and spike’’ prior formulation [4]. Inference can be
made from these models using Markov chain Monte Carlo
(MCMC) [5,6] and this methodology has been extended to the
case of more variables than observations [7,8]. Similar methods
have been proposed for the analysis of SNP data [9,10], which
again utilised MCMC. However, despite design of the MCMC
algorithms to minimise computational time, these methods are too
slow to deal with the size of problem presented by modern SNP
chips. Furthermore, these methods have dealt with the computa-
tionally easier problem of a continuous outcome.
We assign continuous prior distributions with a sharp mode at
zero, often referred to as ‘‘shrinkag’’ priors, to the regression
coefficients. Our approach is Bayesian-inspired rather than fully
Bayesian, since we seek only the posterior mode(s) rather than the full
posterior distribution of the regression coefficients. If the signal of
association at a SNP is weak or non-existent, the posterior mode for
the corresponding covariate will remain at zero. By using continuous
shrinkage priors the resulting posterior density is continuous and can
thus be maximised using standard algorithms. Our stochastic search
maximisation algorithmseeks the (small)subset ofSNPs for which the
posterior mode is non-zero, corresponding to a signal of association
that is strong enough to overcome the prior preference for zero effect.
Thealgorithmcan besetto include onlyadditive effects,orit can also
consider dominant and recessive terms: only one of these terms is
permitted to be non-zero.
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double exponential distribution (DE) and a generalisation of it, the
normal exponential gamma distribution (NEG), which has a
sharper peak at zero and heavier tails, Figure 1. The sharp peak of
the NEG at zero favours sparse solutions which is preferable for
variable selection when we believe that there are few true causal
variables. Further, the heavy tails result in variables being
minimally shrunk once included in the model. The NEG is
characterised by a shape and a scale parameter. The smaller the
shape parameter the heavier the tails of the distribution and the
more peaked at zero. Conversely as the shape parameter increases
the NEG approaches the DE. For both prior distributions we
obtain an explicit expression for the approximate type-I error of
our method, so that it can be calibrated without recourse to
permutation techniques.
With both the NEG and DE prior for n,k, the posterior density
can be multi-modal [11] and the mode identified by each run of
our algorithm depends on the initial values of the parameters and
the order in which they are updated. We implement multiple runs
of the algorithm, always starting with all regression coefficients
equal to zero but permuting the order in which they are updated,
and report the highest of the modes identified. Our checks using
more extensive searches in test datasets indicate that typically the
largest mode identified in our search corresponds to a model that
is very similar to the global optimum model, differing for example
in which of two highly-correlated SNPs is included. We
demonstrate this in our analysis of a real GWA study and show
how the multiple modes found can be utilised to infer a group of
SNPs that identify the same signal.
As a consequence of modelling all SNPs simultaneously, a SNP
will only be included in the model if it significantly improves
prediction of case-control status beyond that obtained from the
SNPs already included. Thus a SNP with strong marginal effect can
be overlookedbyouranalysisifotherSNPs betterexplainmostofits
effect. We typically find that our analysis returns only the best SNP
characterising the effect of a single detectable causal variant, and
when multiple SNPs in close proximity are selected this is an
indication of multiple distinct causal variants. Thus, the number of
SNPs in the best fitting model gives an estimate of the number of
causal variants. This feature of the method also makes it suitable for
fine mapping usingdense SNP sets, such asthose that canarise from
imputation methods or re-sequencing, in contrast with single-SNP
analyses in which many tightly-linked SNPs may show signs of
association, leaving open the problem of locus refinement.
Haplotype and interaction effects could be readily implemented
using our approach, but these would substantially increase the size
of the model space to be explored for genome-wide datasets and
we have not pursued these possibilities here. Our software deals
with quantitative phenotypes, but here we focus on main effect
terms for case-control phenotypes with up to half a million SNPs,
and demonstrate that our method improves on single-SNP
analyses in terms of false-positive rate, power and interpretability.
Results
Main Simulation Study
Our main simulation study used the FREGENE software [12]
to simulate 20 Mb of sequence data in a population of 10 K
individuals with mutation, cross-over and gene-conversion rates
similar to those in humans [13]. From this population we sampled
500 case-control data sets each with six causal variants and 1,000
cases and 1,000 controls. For each simulation we added a further
nineteen 20 Mb chromosomes devoid of causal variants. Thus, in
effect we analysed 400 Mb genomes consisting of twenty equal-
length chromosomes, with all the causal variants concentrated on
one chromosome. Marker SNPs were sampled to give an
approximately uniform minor allele frequency (MAF) distribution
with SNPs spaced on average every 5 Kb, giving 80 K SNPs per
data set. The selection ignored causal status, so that the marker
SNPs usually included few if any of the causal SNPs.
The above data sets were analysed using (i) our algorithm with
an NEG shrinkage prior, (ii) our algorithm with a DE shrinkage
Figure 1. Logarithms of NEG and DE densities. Fixed to have the
same density at the origin.
doi:10.1371/journal.pgen.1000130.g001
Author Summary
Tests of association with disease status are normally
conducted one SNP at a time, ignoring the effects of all
other genotyped SNPs. We developed a computationally
efficient method to simultaneously analyse all SNPs, either
in a genome-wide association (GWA) study, or a fine-
mapping study based on re-sequencing and/or imputa-
tion. The method selects a subset of SNPs that best
predicts disease status, while controlling the type-I error of
the selected SNPs. This brings many advantages over
standard single-SNP approaches, because the signal from a
particular SNP can be more clearly assessed when other
SNPs associated with disease status are already included in
the model. Thus, in comparison with single-SNP analyses,
power is increased and the false positive rate is reduced
because of reduced residual variation. Localisation is also
greatly improved. We demonstrate these advantages over
the widely used single-SNP Armitage Trend Test using
GWA simulation studies, a real GWA dataset, and a
sequence-based fine-mapping simulation study.
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NEG and DE we standardised the genotype data to have mean
zero and variance one. The ATT is the natural univariate
comparison for our multivariate method being a score test for a
regression coefficient in a logistic regression model [14] and we
show in Text S1 that our search procedure, when applied
univariately to standardised data, is asymptotically equivalent to
the ATT. Detailed analyses on a subset of the data identified 0.05
as the most suitable value of the NEG shape parameter l for the
selection of truly causal variants; smaller values gave rise to
computational problems. With l=0.05 the heavy tails of the prior
density (Figure 1), reflect little prior knowledge of effect sizes.
However, standardising the genotypes has the effect of incorpo-
rating a prior belief that effect sizes may be larger at alleles with
smaller MAF [15]. The per-SNP type-I error rate was set at
a=10
25 for all three analyses; see Methods for setting the DE and
NEG parameters to achieve this. The results for the NEG and DE
were based on the highest posterior mode found from 100
permutations of the search order using the optimisation algorithm
described in the Methods.
The definition of true and false positives can be problematic
when, as here, the causal variant is typically not included among
the SNPs analysed. In practice, when a significant result is
obtained all SNPs in strong linkage disequilibrium (LD) with it are
considered as potential sources of the positive signal. For unlinked
SNPs with uniform MAF distribution and typed in 2 K
individuals, the upper 99.9% percentile of the null distribution
of r
2 is about 0.005, and so most SNPs having r
2.0.005 with a
causal variant are in some sense true associations. However, due to
the variable pattern of LD in the human genome, SNPs showing
0.005,r
2,0.05 with a causal variant can sometimes be hundreds
of Kb distant from it, and are likely to be difficult to replicate.
Therefore we chose to classify a positive signal as ‘‘true’’ if it has
r
2.0.05 with any causal SNP. Furthermore, a cluster of tightly
linked false positives might be considered as essentially just one
false positive, and in Table 1 false positives were only counted if
they were further than a specified distance (between 0 Kb and
100 K) away from any other false positive that had already been
recorded.
A feature of both the NEG and DE results is the reduction in
the number of false positives relative to the ATT, despite the fact
that the type-I error rate was set to be the same for all analyses
(Table 1). This reflects one of the principal effects of analysing
SNPs simultaneously: the signal at a SNP that shows spurious
association when analysed singly is often weakened by inclusion in
the model of true positives, which may or may not be tightly linked
with it.
If several SNPs are mutually in high LD, typically at most one of
them will be included in the model. Thus the NEG analysis picked
2,097 SNPs over the 500 data sets, many fewer than the 6,810
SNPs selected using the ATT (Table 1). If a causal SNP is detected
by the NEG method then typically (87% of the time) it will be
tagged by just one selected SNP (Figure 2). In contrast ATT often
picks multiple SNPs for each causal variant and picks one SNP just
31% of the time. The higher number of false positives for ATT
can be attributed in part to the way the ATT picks many more
SNPs per causal variant than the NEG or DE; some of these are
remote from, and in low LD with, the nearest causal variant, and
fail to reach our threshold of r
2.0.05 for useful tagging. However,
the fact that ATT selects many more SNPs than DE or NEG can
spuriously inflate its true power, because some of these additional
significant SNPs will by chance be in LD with one or more causal
variants. In the case of several causal variants, the ATT may
produce what appears to be a single signal.
Of the 3,000 causal SNPs in the simulations, 1,402 are detected
by both the NEG and ATT analyses, 54 are only detected by NEG
and 32 are only detected by ATT. Although this difference in
empirical power is small (0.7%), a p-value for the null hypothesis
that the NEG and ATT are equally powerful is 0.011 (binomial
probability of #32 successes, given 86 trials and success
probability 0.5). Moreover, the NEG empirical power equals or
exceeds that of ATT for all six combinations of MAF and allelic
risk ratio (Table 2). Thus we have evidence of improved power of
NEG over ATT, in addition to its lower false positive rate.
Table 1. Main simulation study: the results shown are
summed over the 500 datasets each with 6 causal variants; a
causal variant is ‘‘tagged’’ if $1 selected SNP has r
2.0.05 with
it.
Method
SNPs
selected
Causal SNPs
tagged
False positives minimum
separation (Kb)
0 2 04 01 0 0
NEG 2097 1576 368 368 368 366
DE 2622 1501 297 277 276 271
ATT 6810 1554 696 536 486 441
doi:10.1371/journal.pgen.1000130.t001
Figure 2. Main simulation study. Histograms of the number of
selected SNPs tagging (at r
2.0.05) each causal SNP for (A) NEG and (B)
ATT analyses.
doi:10.1371/journal.pgen.1000130.g002
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causal SNPs even though it selects 2,622 SNPs, many more than
NEG (Table 1). The lighter tails of the DE distribution in
comparison with the NEG result in informative variables being
shrunk closer to zero. This can result in other correlated SNPs
being brought into the model to explain the full effect of the over-
shrunk SNP coefficients.
Our preliminary analyses varying l showed that as l increased
the false positive rate decreased but the power also decreased and
in doing so approached the results obtained with the DE prior.
With l=10 the results were very similar to the DE results.
Null Simulation
To validate our type-I error rate approximation, and to assess
the effect on type-I error of allowing for dominant and recessive
effects, we permuted the case-control status in one of the 80 K
data sets to generate 1,000 data sets representing samples from the
null of no genetic effects. The resulting per-SNP type-I error rates
of the NEG, DE and ATT methods are shown in Table 3. False
positives were only counted if they were further than 20 Kb away
from any other false positive that had already been recorded,
however the results were the same when the minimum separation
was 100 Kb. The type-I error rate was highest for ATT although
the differences are not significant. All three analyses result in
noticeably fewer false positives than the nominal rate of a=10
25.
Because of LD between SNPs it is not easy to decide if this
difference is significant, but it suggests that our type-I error
approximation is as conservative as that of the ATT, which is
based on the x2
1 approximation.
When dominant and recessive effects are considered in addition
to additive terms, the false positive rate approximately doubles.
Thus parameter settings that control the type-I error at 2.5% for
additive effects will approximately control the type-I error at 5%
when dominant and recessive effects are also included. Recall that
our simulations generated an approximately uniform MAF
distribution of the marker SNPs, and this result may vary with
different MAF distributions.
Whole Genome Simulation Study
We also generated a data set corresponding to a genome-wide
association study consisting of 480 K SNPs, derived from 120
independent 20 Mb chromosomes using the same SNP ascertain-
ment strategy as used in the previous simulation. We chose one
20 Mb chromosome to have ten causal variants each with MAF of
15% and allelic risk ratio of 2. This disease model is unrealistic but
was chosen to permit detection of the majority of the causal
variants and thus make general comments on the relative merits of
the NEG and ATT in one simulation.
We analysed this data set as before using the NEG and ATT but
with a significance threshold of a=5 610
27 [16]. As before, we
chose the highest posterior mode from 100 permutations of the
search order.
Figure 3(A) shows the locations along the 20 Mb chromosome
of the ten causal variants, as well as all the SNPs selected by the
NEG and ATT analyses. Both methods have detected all ten
causal variants, however the NEG analysis selected just 14 SNPs,
whereas the ATT identified 35 significant SNPs. We see in
Figure 3B that the NEG analysis has improved localisation, it
ignores SNPs remote from causal variants that were significant
under the ATT, in particular at 8.3 Mb, and has selected SNPs as
close to the causal variant as the ATT has. In Figure 3C the
improvement in localisation is less clear, the ATT has selected
SNPs closer to causal variant, but at the expense of selecting many
more SNPs. In particular the ATT has selected SNPs at 11.5 Mb,
about 400 Kb from the causal variant.
Re-Sequencing Simulation Study
Fine mapping of causal variants currently uses very high density
markers, obtained either directly from resequencing or from
imputation following limited resequencing or from high-density
SNPs in public databases [17,16,18]. To illustrate the utility of our
method for the analysis of imputed and/or sequence data we took
the simulated 20 Mb sequences of 10 K individuals used in the
previousanalyses,which had 192 Kpolymorphicsites,and sampled
10 case-control datasets using the same sample sizes and disease
model as used in the main simulation. All polymorphic sites were
included in our analyses. The data sets were analysed with the NEG
and ATT with a per-SNP false positive rate of a=10
25.
The ATT and NEG analyses showed similar power over the ten
sequence-level datasets. Both methods detected 54 of the 60 causal
variants with r
2.0.3, five causal SNPs were missed entirely by
both methods and one causal SNP was tagged by both methods at
r
2<0.01. However, NEG showed markedly better localisation than
ATT. Figure 4 shows the distribution of the highest r
2 value for
each selected SNP with a causal variant using the two methods.
The NEG selected just 64 SNPs in comparison with 599 selected
by the ATT, and a greater proportion of the selected SNPs were in
high LD with a causal variant. Of the 60 causal variants, only nine
were tagged twice by NEG, in contrast, it is evident from Figure 4
that the ATT often multiply tags causal SNPs. In no simulation
did a SNP selected by NEG tag two causal SNPs.
The NEG analysis identified two false positive SNPs at the less
stringent r
2=0.01 threshold for tagging a causal SNP. The ATT
analysis generated 14 false positives at this threshold; 11 of these
SNPs spanned a 230 Kb region including one of the NEG false
positives, while two spanned a 103 Kb region including the other
Table 2. Main simulation study: numbers of causal SNPs
tagged, out of the 500 for each MAF and risk ratio.
Method MAF and allelic risk ratio
15% 5% 2%
1.4 1.5 1.8 2.2 2.5 3.0
NEG 252 360 209 370 146 239
DE 233 347 194 366 135 227
ATT 244 353 209 370 143 235
doi:10.1371/journal.pgen.1000130.t002
Table 3. Null simulation: empirical per-SNP type-I error rates
from 1,000 permutations of case-control labels of 2 K
individuals genotyped at 80 K SNPs.
Method Error rate (per million SNPs)
Additive only
Additive, dominant
and recessive terms
NEG 6.44 12.8
DE 6.39 12.7
ATT 6.48 -
In each case the nominal per-SNP type-I error rate for the additive-only model
was 10
25 (=10 per million SNPs).
doi:10.1371/journal.pgen.1000130.t003
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2=0.009
with a causal variant.
Analysis of Type 2 Diabetes GWA Data Set
From a genome-wide scan on 694 type 2 diabetes cases and 654
controls [19], we reanalyse here genotype data from the Human
Hap300 BeadArray, but not the Human Hap100 BeadArray. After
removing SNPs with Hardy-Weinberg equilibrium p-value ,10
23
or with call rate ,0.95, there were 300,535 SNPs analysed.
In the original analysis [19], SNPs were tested for additive,
dominant and recessive effects and 42 were significant (permuta-
tion p-value ,5610
25), tagging 32 distinct loci (defined here to
denote a 1 Mb flanking region). These SNPs, together with 15
SNPs identified using the Human Hap100 BeadArray, were
carried forward to a replication analysis using 2,617 cases and
2,894 controls [19] that confirmed eight SNPs tagging five loci.
Our NEG reanalysis used l=0.05, while c was set such that
a=2.5610
25 if additive effects only were considered, thus
approximately controlling the type-I error rate at 5610
25 for
our actual analysis which also considered dominant and recessive
terms. The resulting best-fitting model included 26 SNPs, tagging
25 distinct loci including the five previously-replicated loci
(Table 4). Four of our SNPs matched those previously reported
while the fifth locus had been tagged by Human Hap100
Figure 3. GWA simulation. (A) locations of the ten causal variants (vertical blue line) on the 20 Mb chromosome; also shown are the SNPs selected
by NEG (red dots), and the SNPs with ATT p-value 5610
27 (black dots) plotted against 2log10 (p-value). (B) and (C) show zooms of two sub-intervals
of (A).
doi:10.1371/journal.pgen.1000130.g003
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identified rs729287 only 20 Kb distant.
We also looked at the seven other best-fitting modes with
posterior density within a factor of 10 of the maximum. These
modes included 29 unique SNPs. The three extra SNPs in this
combined list not included in the best fitting mode were all within
50 Kb of SNPs included in the best fitting mode. In modes which
included one of these extra SNPs, the SNP close by was not
included. Thus, examining sup-optimal modes can identify
alternate SNPs tagging the same causal variants, which can be
useful to include in follow-up genotyping when some redundancy
is beneficial, or to consider alternative possibilities for the SNP in
strongest LD with the causal variant. The SNPs tagging the five
previously replicated loci were included in all seven modes
suggesting that these are the best tagging SNPs for the causal loci.
These results are consistent with the conclusions from our
simulation study: we captured the same significant loci as the
single-SNP analysis but at the cost of many fewer false positives. In
addition, our NEG analysis has picked one SNP from each of the
replicated loci, suggesting that there is just one distinct causal
variant in each locus tagged by the genotyped SNPs.
Discussion
Our NEG shrinkage-based algorithm provides a computation-
ally-efficient tool for the simultaneous analysis of either genome-
wide SNPs or resequencing or hyper-dense SNPs from large
regions. The NEG analysis improves on the single-SNP ATT
analysis, most notably in terms of false positives, and also in terms
of power. It is also superior to the DE analysis in terms of of
power, at the expense of a higher false positive rate. The NEG
method typically selects one SNP for each causal variant and thus
gives a measure of the number of underlying causal SNPs
genotyped in the data set under study, as well as improving
localisation in comparison with the ATT.
The advantages of the NEG analysis are even greater for
sequence or very-high density genotype data, such as can be
obtained via imputation: it identifies a much smaller subset of
SNPs without a reduction of power, and tags the causal variants
with higher r
2 on average. This reflects the natural advantage of a
regression-based approach when causal variants are included in
the analysis rather than merely tagged by markers.
Significant SNPs from a GWA are usually genotyped in another
sample. With cheaper genotyping experimenters may be able to
afford to replicate more SNPs than the minimal set suggested by the
NEG or DE methods. Candidates for redundant/alternative SNPs
canbe obtained byconsidering local modes found by ouralgorithm.
A full Bayesian analysis such as that suggested in [20] would also be
possible if limited to a subset of SNPs, and would explore the
posterior distribution more completely for that SNP-set.
Since we take a regression approach it would be straightforward
to include other individual level covariates such as age and sex, as
well as covariates to control for population stratification such as
eigenvectors from a principal component analysis [21]. Our
software can analyse quantitative traits and could be extended to
search for haplotype or interaction effects. In the latter case the
size of the model space would need to be reduced, perhaps by a
strategy of seeking interactions of all SNPs with those SNPs
showing marginally significant association. There is growing
interest in predicting phenotypes from genotypes in both human
genetics [22] and livestock genetics, in which there is interest in
predicting breeding values [9]. Since our method is regression
based and considers all SNPs simultaneously and will thus account
for the LD between SNPs [23], it can also address this application;
a weaker significance threshold is often considered appropriate for
prediction rather than SNP selection.
Software can be downloaded from http://www.ebi.ac.uk/
projects/BARGEN/.
Methods
Shrinkage Priors
For each regression coefficient we assign independent shrinkage
priors with a density that is sharply peaked at zero. The DE is a
one-parameter distribution that is widely used as a shrinkage prior
Figure 4. Re-sequencing simulation. Histograms of the maximum
r
2 for each selected SNP with a causal variant for (A) NEG and (B) ATT
analyses.
doi:10.1371/journal.pgen.1000130.g004
Table 4. SNPs included in the best-fitting model for
association with type 2 diabetes from the NEG analysis of
Human Hap300 BeadArray genotype data that were validated
in a second stage analysis [19].
SNP Chromosome Position Closest gene Model
rs13266634 8 118,253,964 SLC30A8 Dominant
rs7923837 10 94,471,897 HHEX Additive
rs7903146 10 114,748,339 TCFL2 Additive
rs7480010 11 42,203,294 LOC387761 Dominant
rs729287 11 44,236,666 EXT2 Dominant
doi:10.1371/journal.pgen.1000130.t004
Simultaneous Analysis of GWAs
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distribution:
DE bj j ðÞ ~
ð?
0
N b 0,s2       
Ga s2 1,j
2 
2
      
ds2~
j
2
exp {jb jj fg ,
ð1Þ
where N(a,b) is the normal density with mean a and variance b and
Ga (c,d) is the gamma density with shape parameter a and scale
parameter b.
The normal exponential gamma distribution [2] is a general-
isation of the DE that has the following scale mixture
representation:
NEG bl ,c j ðÞ ~
ð?
0
ð?
0
N b 0,s2       
Ga s2 1,y j
  
Ga yl ,c2       
ds2dy
~k exp
b
2
4c2
 !
D{2l{1
b jj
c
  
,
ð2Þ
where l and c can be interpreted as shape and scale parameters
respectively, k is the integrating constant and D is the parabolic
cylinder function [24]. We can see from (1) and (2) that the NEG
can be generated by sampling from a DE distribution with
parameter drawn from a gamma distribution. There is a fast
algorithm for computing D and its derivatives [25], and Fortran
code is available from http://jin.ece.uiuc.edu/routines/routines.
html.
As l and c both increase such that j~
ﬃﬃﬃﬃﬃ
2l
p .
c remains constant,
the NEG converges to the DE distribution with parameter j.
Figure 1 shows the log densities of the DE and three NEG
distributions, all with the same density at zero. From the plot we
see that as l decreases the NEG density is steeper near zero and
flatter elsewhere, thus shrinking non-zero coefficients less than the
DE. For further details of the NEG see Text S1.
The Optimisation Algorithm
We seek to maximise the posterior density p (b | x,y) over
b=(b1,…, bk), where x=(x11,…,xnk) is the normalised genotype
data and y=(y1,…,yn) denotes the case-control status coded as 1
for cases and 21 for controls. Taking logarithms in Bayes
Theorem we can write
log p b x,y j ðÞ ~L b ðÞ {f b ðÞ zconst, ð3Þ
where L denotes the log-likelihood for the logistic regression model
and f is minus the log-prior density. The negative sign is
introduced to allow f to be interpreted as a penalty function,
and so our estimation procedure can be thought of as maximising
a penalised log-likelihood. With the DE prior, the maximisation of
(3) is equivalent to the Lasso procedure [26]. The EM algorithm
has been used for the analogous optimisation problem for linear
regression [2] but we found it to converge slowly for binary
regression. Instead we use the CLG algorithm [27] which
optimises each variable in turn, making multiple passes over the
variables until a convergence criterion is met. This algorithm has
been implemented for the logistic regression model [1], but not
previously with the NEG prior.
There is no closed form solution for the univariate optimisation
problem in logistic regression, but Newton’s method can be
applied using the formula
b
new
j ~bj{
L0 b ðÞ {f 0 bj
  
L00 b ðÞ {f 00 bj
   , ð4Þ
where each 9 denotes a derivative with respect to bj, and
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expgi
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2
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where gi~yi b0z
Pk
j~1 bjxij
  
. See Text S1 for justifications.
We avoid taking large steps by replacing the L0 with an upper
bound [1]. We also disallow any update proposed according to (4)
that would change the sign of b:i n s t e a d ,b
new
j is set to zero. When
bj=0 the algorithm attempts an update in both directions, taking
limits as bj approaches zero from above and below, and accepting the
move if b
new
j is, respectively, positive or negative. Since the
denominator in (4) is always negative at bj=0, and f is symmetric
about zero so that f9(0
+)=2f9(0
2), where 0
+and 0
2denote the limits
from above and below, it follows that a move of bj away from the
origin occurs whenever
L0 bj~0
          wf 0 bj~0z   
: ð6Þ
The calculation of L9 involves a sum over all individuals and is
computationally expensive. Moreover, recall that the 9 denotes
derivative with respect to bj and so L9 is required for each j. However,
computationally-fast upper and lower bounds for L9 can be derived
(see Text S1), which in conjunction with (6), determine whether a
movefrombj=0 ispossible. Checking thisbound avoids the necessity
to compute L9 for all but a small proportion of values of j.
Assigning Prior Parameters to Control Type-I Error
From (6) we can derive an explicit approximation for the type-I
error rate of our procedure. We reject the null if the posterior mode
is not at b=0. By standardising the genotype data to have mean
zero and variance one, the type-I error probability is the same for
each SNP, regardless of MAF. By writing |L9(b)| in terms of ^ b b, the
maximum likelihood estimate of b, and assuming asymptotic
normality of ^ b b, the per-SNP type-I error rate will be a if
f 0 b~0z ðÞ ~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n0n1
n0zn1
r
W{1 1{a=2 ðÞ , ð7Þ
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21 is
the inverse normal distribution function; see Text S1 for the
derivation. To maintain the same type-I error the prior must be
chosen such that the penalty f9 increases as the sample size
increases. It can be shown that this criterion for controlling the type-
I error, when applied multivariately to equal numbers of cases and
controls,givesrisetoasmallertype-Ierrorrateonceoneormoreb’s
are non-zero; see Text S1.
For the DE prior f9(b)=j for all b.0, thus to control the type-I
error at a we assign j to equal the right hand side of (7). For the
NEG prior, the value of f9 (b) is given in (5). The NEG has two
parameters, whereas (7) imposes only one constraint. We
considered a range of values for the shape parameter l from
0.01 to 10 and then assign c by substituting (7) into (5) and
rearranging.
Both the NEG and DE behave similarly when they have been
set to have the same type-I error, when their derivative at the
origin is the same, and when b=0. Solutions diverge however
once SNPs are included in the model, since included SNPs are
penalised less by the NEG than by the DE. This results in larger
parameter estimates using the NEG, and affects how likely a
variable is to be pushed out of the model once it has been
included.
Including Dominant and Recessive Effects
So far, the genotype variable xij is the allele count, standardised
to have mean zero and variance one. This corresponds to a model
that is additive on the logistic scale. To implement a search for
dominant or recessive effects, we simply recode this variable
accordingly. For example, to seek a recessive effect, we assign
xij=2u if individual i is heterozygote or major-allele homozygote
at SNPj, and xij=v otherwise, where u and v are chosen to
standardise xij. When dominant and recessive effects were included
in the model they were considered in the following order: (1)
additive, (2) dominant, (3) recessive; terms (2) and (3) are only
considered if no preceding term is already included in the model at
that SNP.
Simulation Study
The allelic risk ratios were multiplicative within and across loci
and the disease prevalence was 12%; the multiplicative disease
model is similar to, but not the same as, the logistic regression
model on which our analyses are based. Two causal SNPs were
chosen with each of the following approximate MAF values: 2%,
5%, and 15%. The two allelic risk ratios for each MAF were
chosen so that the power to detect an association was around 25%
and 75% using the ATT at a significance threshold of 10
25, see
Table 2 for the effect sizes. With this disease model, the
background disease risk is typically <6% for individuals carrying
no causal alleles, and this risk can be attributed either to polygenic
or environmental effects. Thus, although we explicitly simulate six
causal alleles, this does not exclude multiple weaker causal alleles
that are unlikely to be detected.
Marker SNPs were sampled randomly from disjoint 5 Kb
regions on each chromosome with probability proportional to
MAF(1–MAF), resulting in an approximately uniform MAF
distribution.
Supporting Information
Text S1 Simultaneous Analysis of all SNPs in a Genome-Wide
Association Study.
Found at: doi:10.1371/journal.pgen.1000130.s001 (0.07 MB PDF)
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